Replies to post #94156 on Decision Diagnostics Corp (DECN)

[rawman]

So, besides threats, what 2 or 3 posts would you reference as the most blatant Berman post/pumps, that weren't repeats of information in prior PRs?

I am speculating that posting on a public investment forum, without identifying oneself as a company insider or spokesperson, is at the very least an SEC Reg FD violation. A standalone Reg FD violation would be a civil matter.

OTOH, if the posts included serious misrepresentations by the "spokesperson", i.e. CEO Keith Berman, the associated violations could be construed as securities fraud. Securities fraud is a criminal matter. Berman's grand jury criminal indictment seems to focus on the PR's, but the following was included in the criminal indictment:

BERMAN used an alias to post positive messages about DECN's business and operations on investor message boards, in order to artificially increase and maintain the share of DECN securities; (SECURITIES FRAUD?)

Here's another one:

BERMAN used an alias to post messages on investor message boards refuting allegations that BERMAN had made false and misleading public statements about DECN's business and operations and BERMAN's use of corporate funds, and otherwise making lulling statements to actual and potential investors in DECN securities;

Either way, the SEC does not look kindly on company affiliates or "paid consultants", who hide behind an alias to communicate on public forums or chat rooms.

[rawman]

Interestingly, upon re-reading the SEC's 21 page civil action against CEO Keith Berman and DECN, it seems there is no mention of Berman's use of an alias to promote DECN on public message boards. It appears all the charges related to Berman's posting activiites are contained in the DOJ's criminal indictment. The SEC relied on the BS Press Releases Berman authored and distributed between March 3, 2020 and April 23, 2020.

Interestingly, all of the bogus claims, as cited in the SEC charges, were previously exposed by the contrarian posters on this iHUB Board. Forgetting all the overstatements and inconsistencies, thanks to IP Watcher and several others, we knew that sampling blood would NEVER ever work for identifying an active COVID-19 infection. So did Berman's pal and science consultant, Matthew Musho!